Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo

Published:2020-01 Issue: Volume:151 Page:104512
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Liu Zhuojun,Liu Jia,Zhang Tianming,Shi Mingxia,Chen Xiaofang,Chen Yun,Yu Jian

Funder

National Natural Science Foundation of China

Beijing Advanced Innovation Center Research Foundation

Publisher

Elsevier BV

Subject

Pharmacology

Reference42 articles.

1. ROR1 can interact with TCL1 and enhance leukemogenesis in Emu-TCL1 transgenic mice;Widhopf;Proc. Natl. Acad. Sci. U.S.A.,2014

2. Monoclonal antibod ies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells;Daneshmanesh;Leukemia,2012

3. Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells;Hojjat-Farsangi;PLoS One,2013

4. Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies;Yang;PLoS One,2011

5. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a;Fukuda;Proc. Natl. Acad. Sci. U.S.A.,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies;Science China Life Sciences;2024-08-12

2. Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress;Archives of Pharmacal Research;2024-04-17

3. Role of the Ror family receptors in Wnt5a signaling;In Vitro Cellular & Developmental Biology - Animal;2024-04-08

4. Targeting Other Promising Cell Surface Receptors;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

5. How receptor tyrosine kinase‐like orphan receptor 1 meets its partners in chronic lymphocytic leukemia;Hematological Oncology;2024-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3